@article{bb0ffdda675c4ce7ae6f0377dfad6cf5,
title = "Inferring structural variant cancer cell fraction",
abstract = "We present SVclone, a computational method for inferring the cancer cell fraction of structural variant (SV) breakpoints from whole-genome sequencing data. SVclone accurately determines the variant allele frequencies of both SV breakends, then simultaneously estimates the cancer cell fraction and SV copy number. We assess performance using in silico mixtures of real samples, at known proportions, created from two clonal metastases from the same patient. We find that SVclone{\textquoteright}s performance is comparable to single-nucleotide variant-based methods, despite having an order of magnitude fewer data points. As part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) consortium, which aggregated whole-genome sequencing data from 2658 cancers across 38 tumour types, we use SVclone to reveal a subset of liver, ovarian and pancreatic cancers with subclonally enriched copy-number neutral rearrangements that show decreased overall survival. SVclone enables improved characterisation of SV intra-tumour heterogeneity.",
author = "{PCAWG Evolution and Heterogeneity Working Group} and {PCAWG Consortium} and Marek Cmero and Ke Yuan and Ong, {Cheng Soon} and Jan Schr{\"o}der and Adams, {David J.} and Pavana Anur and Rameen Beroukhim and Boutros, {Paul C.} and Bowtell, {David D.L.} and Campbell, {Peter J.} and Shaolong Cao and Christie, {Elizabeth L.} and Yupeng Cun and Dawson, {Kevin J.} and Jonas Demeulemeester and Dentro, {Stefan C.} and Deshwar, {Amit G.} and Nilgun Donmez and Drews, {Ruben M.} and Roland Eils and Yu Fan and Fittall, {Matthew W.} and Garsed, {Dale W.} and Moritz Gerstung and Gad Getz and Santiago Gonzalez and Gavin Ha and Kerstin Haase and Marcin Imielinski and Lara Jerman and Yuan Ji and Clemency Jolly and Kortine Kleinheinz and Juhee Lee and Henry Lee-Six and Ignaty Leshchiner and Dimitri Livitz and Salem Malikic and I{\~n}igo Martincorena and Mitchell, {Thomas J.} and Morris, {Quaid D.} and Ville Mustonen and Layla Oesper and Martin Peifer and Myron Peto and Raphael, {Benjamin J.} and Daniel Rosebrock and Yulia Rubanova and Sahinalp, {S. Cenk} and Adriana Salcedo",
note = "Funding Information: We would like to thank Kangbo Mo for his assistance in developing the SV classification scheme during his Master studies, and Christoffer Flensburg for his helpful advice for the four-and five-cluster mixtures. F.M., G.M. and K.Y. would like to acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. G.M., K.Y. and F.M. were funded by CRUK grants C14303/A17197 and A19274. G.M. was funded by CRUK grant A15973. This work was supported, in part, by NHMRC grants 1047581 and 1104010 to C.M.H. and 1024081 to N.M.C as well as a VCA early career seed grant 14010 to NMC. NMC was supported by a David Bickart Clinician Researcher Fellowship from the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and more recently by a Movember – Distinguished Gentleman{\textquoteright}s Ride Clinician Scientist Award through the Prostate Cancer Foundation of Australia{\textquoteright}s Research Program. M.C. would like to acknowledge the support of the Cybec Foundation and the Endeavour Research Fellowship. We acknowledge the contributions of the many clinical networks across ICGC and TCGA who provided samples and data to the PCAWG Consortium, and the contributions of the Technical Working Group and the Germline Working Group of the PCAWG Consortium for collation, realignment and harmonised variant calling of the cancer genomes used in this study. We thank the patients and their families for their participation in the individual ICGC and TCGA projects. Publisher Copyright: {\textcopyright} 2020, The Author(s).",
year = "2020",
month = dec,
day = "1",
doi = "10.1038/s41467-020-14351-8",
language = "English (US)",
volume = "11",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",
}